Interaction effect of functional variants of the BDNF and DRD2/ANKK1 gene is associated with alexithymia in healthy human subjects

• Published in: Psychosomatic medicine Vol. 73; no. 1; p. 23
• Main Authors: Walter, Nora T, Montag, Christian, Markett, Sebastian A, Reuter, Martin
• Format: Journal Article
• Language: English
• Published: United States 01.01.2011
• Subjects: Adult; Affective Symptoms - diagnosis; Affective Symptoms - genetics; Ankyrin Repeat - genetics; Brain-Derived Neurotrophic Factor - genetics; Emotions - physiology; Female; Genetic Association Studies; Genetic Variation; Genotype; Gyrus Cinguli - anatomy & histology; Gyrus Cinguli - physiology; Heterozygote; Humans; Male; Methionine - genetics; Personality - genetics; Personality Inventory; Polymorphism, Genetic; Protein-Serine-Threonine Kinases - genetics; Receptors, Dopamine D2 - genetics; Surveys and Questionnaires; Valine - genetics
• ISSN: 1534-7796
• DOI: 10.1097/PSY.0b013e31820037c1

To test the hypothesis that the interaction between the brain-derived neurotrophic factor (BDNF) and dopamine receptor D(2) (DRD2)/ANKK1 gene contributes to individual differences in alexithymia. The personality construct of alexithymia refers to difficulties in emotional self-regulation and contributes as a risk factor to several mental disorders. Alexithymic individuals show an impoverished conscious experience of emotions but an intact autonomic emotional response. Persons with high alexithymia scores reportedly show a reduced activation of the anterior cingulate cortex (ACC) during the processing of emotional stimuli. An interaction between two polymorphisms on the BDNF and DRD2/ANKK1 gene has been recently associated with reduced gray matter volume in the ACC and higher trait anxiety. We conducted a genetic association study. A total of 664 healthy participants completed the Toronto Alexithymia Scale questionnaire and were genotyped for the BDNF Val66Met (rs6265) and the DRD2/ANKK1 Taq IA (rs1800497) polymorphisms. Carriers of at least one BDNF 66Met and one DRD2/ANKK1 A1 allele showed the highest scores in the total Toronto Alexithymia Scale and in the subscale "Difficulties Identifying Feelings." In line with recent studies investigating the role of BDNF Val66Met and DRD2/ANKK1 Taq IA polymorphisms on anxiety and gray matter volume in the ACC, our findings provide the first evidence for a genetic contribution to alexithymia.